EUVIMEDEUVIMED entdecken
Crossref

High Rate of HIV-1 Drug Resistance in Antiretroviral Therapy-Failure Patients in Liaoning Province, China

Qianqian Wei, Yan Zhao, Yani Lv, Xu Kang, Shan Pan, Shujie Yao, Li Wang iD

AIDS Research and Human Retroviruses · 2022-06 · 38 (6) · 502-509

DOI: 10.1089/aid.2021.0079 ↗

Kurz gefasst

Fachartikel in der Zeitschrift AIDS Research and Human Retroviruses, online erschienen am 06.06.2022. Verfasst von Qianqian Wei und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Preventive Medicine of China Medical University, Shenyang, China. Hauptthemen laut MEDLINE: Anti-HIV Agents, HIV Infections, HIV Seropositivity, HIV-1. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 41 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study aimed to monitor the prevalence of HIV-1 drug resistance and risk factors associated with drug resistance in antiretroviral therapy (ART)-failure individuals in Liaoning Province, China. Plasma samples were collected from HIV-1-positive individuals who experienced ART failure in Liaoning Province between April 2018 and September 2019. Genotype resistance test was performed using an in-house assay on these collected samples. Factors associated with drug resistance were identified by logistic regression analysis. We collected a total of 468 ART-failure individuals, of which 256 were successfully included in the final study. Of these, the most predominant genotype was CRF01_AE, accounting for 77.73%. The resistance rate to any of the three classes of antiretroviral drugs (non-nucleoside reverse transcriptase inhibitors [NNRTIs], nucleoside reverse transcriptase inhibitors [NRTIs], and protease inhibitors [PIs]) was 64.84%. Among 256 ART-failure patients, 62.89% showed drug resistance to NNRTIs, 50.39% to NRTIs, and 3.13% to PIs. G190S (31.25%) and Y181C (25.78%) mutations were the most common NNRTIs resistance mutations. K65R (29.69%), M184V (28.52%) were the most common NRTIs resistance mutations. Factors associated with drug resistance included current ART regimen and viral load. The high drug resistance rate among ART-failure individuals in Liaoning Province needs more attention. Corresponding strategies for the risk factors associated with HIV drug resistance can better control and prevent the prevalence of resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-HIV AgentsHIV InfectionsHIV SeropositivityHIV-1Anti-Retroviral AgentsChinaDrug Resistance, ViralGenotypeHumansMutationReverse Transcriptase InhibitorsViral Load

Stichwörter der Autor:innen

ART failureHIVantiretroviral therapydrug resistance

Substanzen

Anti-HIV AgentsAnti-Retroviral AgentsReverse Transcriptase Inhibitors

Autor:innen und Institutionen

  • Institute for Preventive Medicine of China Medical University, Shenyang, China.
  • Institute for AIDS/STD Control and Prevention, Liaoning Provincial Center for Disease Prevention and Control, Shenyang, China.

ORCID-Profile: Li Wang

Zitieren

APA

Wei, Q., Zhao, Y., Lv, Y., Kang, X., Pan, S., Yao, S., & Wang, L. (2022). High Rate of HIV-1 Drug Resistance in Antiretroviral Therapy-Failure Patients in Liaoning Province, China. AIDS Research and Human Retroviruses, 38(6), 502-509. https://doi.org/10.1089/aid.2021.0079

Vancouver

Wei Q, Zhao Y, Lv Y, Kang X, Pan S, Yao S, et al. High Rate of HIV-1 Drug Resistance in Antiretroviral Therapy-Failure Patients in Liaoning Province, China. AIDS Research and Human Retroviruses. 2022;38(6):502-509. doi:10.1089/aid.2021.0079

BibTeX
@article{Wei2022,
  author = {Wei, Qianqian and Zhao, Yan and Lv, Yani and Kang, Xu and Pan, Shan and Yao, Shujie and Wang, Li},
  title = {High Rate of HIV-1 Drug Resistance in Antiretroviral Therapy-Failure Patients in Liaoning Province, China},
  journal = {AIDS Research and Human Retroviruses},
  year = {2022},
  volume = {38},
  number = {6},
  pages = {502--509},
  doi = {10.1089/aid.2021.0079}
}
Kostenlos starten →